Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.

Navarro A, Moises J, Santasusagna S, Marrades RM, Viñolas N, Castellano JJ, Canals J, Muñoz C, Ramírez J, Molins L, Monzo M.

BMC Pulm Med. 2019 Feb 28;19(1):55. doi: 10.1186/s12890-019-0816-8.

2.

Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery.

Navarro A, Molins L, Marrades RM, Moises J, Viñolas N, Morales S, Canals J, Castellano JJ, Ramírez J, Monzo M.

Cancers (Basel). 2019 Feb 21;11(2). pii: E249. doi: 10.3390/cancers11020249.

3.

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.

Campayo M, Navarro A, Benítez JC, Santasusagna S, Ferrer C, Monzó M, Cirera L.

PLoS One. 2018 Nov 2;13(11):e0206542. doi: 10.1371/journal.pone.0206542. eCollection 2018.

4.

Rotational Instability after Anterior Talofibular and Calcaneofibular Ligament Section: The Experimental Basis for the Ankle Pivot Test.

Guerra-Pinto F, Côrte-Real N, Mota Gomes T, Silva MD, Consciência JG, Monzo M, Oliva XM.

J Foot Ankle Surg. 2018 Nov - Dec;57(6):1087-1091. doi: 10.1053/j.jfas.2018.03.038. Epub 2018 Aug 23.

PMID:
30146335
5.

Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients.

Santasusagna S, Moreno I, Navarro A, Martinez Rodenas F, Hernández R, Castellano JJ, Muñoz C, Monzo M.

Oncology. 2018;95(5):309-318. doi: 10.1159/000490726. Epub 2018 Aug 23.

PMID:
30138915
6.

Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer.

Santasusagna S, Moreno I, Navarro A, Castellano JJ, Martinez F, Hernández R, Muñoz C, Monzo M.

Transl Oncol. 2018 Jun;11(3):715-721. doi: 10.1016/j.tranon.2018.03.010. Epub 2018 Apr 13.

7.

miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.

Santasusagna S, Moreno I, Navarro A, Muñoz C, Martinez F, Hernández R, Castellano JJ, Monzo M.

Clin Transl Oncol. 2018 Sep;20(9):1161-1167. doi: 10.1007/s12094-018-1836-1. Epub 2018 Jan 26.

8.

NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer.

Moisés J, Navarro A, Santasusagna S, Viñolas N, Molins L, Ramirez J, Osorio J, Saco A, Castellano JJ, Muñoz C, Morales S, Monzó M, Marrades RM.

BMC Pulm Med. 2017 Dec 13;17(1):197. doi: 10.1186/s12890-017-0542-z.

9.

Epigenetic regulation mechanisms of microRNA expression.

Morales S, Monzo M, Navarro A.

Biomol Concepts. 2017 Dec 20;8(5-6):203-212. doi: 10.1515/bmc-2017-0024. Review.

PMID:
29161231
10.

Non-Coding RNAs in Hodgkin Lymphoma.

Cordeiro A, Monzó M, Navarro A.

Int J Mol Sci. 2017 May 29;18(6). pii: E1154. doi: 10.3390/ijms18061154. Review.

11.

Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer.

Monzo M, Santasusagna S, Moreno I, Martinez F, Hernández R, Muñoz C, Castellano JJ, Moreno J, Navarro A.

Oncotarget. 2017 May 9;8(19):30859-30869. doi: 10.18632/oncotarget.16103.

12.

Talonavicular joint arthroscopic portals: A cadaveric study of feasibility and safety.

Xavier G, Oliva XM, Rotinen M, Monzo M.

Foot Ankle Surg. 2016 Sep;22(3):205-209. doi: 10.1016/j.fas.2015.08.005. Epub 2015 Sep 25.

PMID:
27502232
13.

LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.

Castellano JJ, Navarro A, Viñolas N, Marrades RM, Moises J, Cordeiro A, Saco A, Muñoz C, Fuster D, Molins L, Ramirez J, Monzo M.

J Thorac Oncol. 2016 Dec;11(12):2173-2182. doi: 10.1016/j.jtho.2016.07.015. Epub 2016 Aug 2.

14.

PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.

Cordeiro A, Navarro A, Gaya A, Díaz-Beyá M, Gonzalez-Farré B, Castellano JJ, Fuster D, Martínez C, Martínez A, Monzó M.

Oncotarget. 2016 Jul 19;7(29):46002-46013. doi: 10.18632/oncotarget.10015.

15.

YKT6 expression, exosome release, and survival in non-small cell lung cancer.

Ruiz-Martinez M, Navarro A, Marrades RM, Viñolas N, Santasusagna S, Muñoz C, Ramírez J, Molins L, Monzo M.

Oncotarget. 2016 Aug 9;7(32):51515-51524. doi: 10.18632/oncotarget.9862.

16.

Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.

Caritg O, Navarro A, Moreno I, Martínez-Rodenas F, Cordeiro A, Muñoz C, Ruiz-Martinez M, Santasusagna S, Castellano JJ, Monzó M.

Clin Colorectal Cancer. 2016 Dec;15(4):e175-e182. doi: 10.1016/j.clcc.2016.04.008. Epub 2016 May 7.

PMID:
27247088
17.

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia.

Navarro A, Pairet S, Álvarez-Larrán A, Pons A, Ferrer G, Longarón R, Fernández-Rodríguez C, Camacho L, Monzó M, Besses C, Bellosillo B.

Blood Cancer J. 2016 Mar 18;6:e406. doi: 10.1038/bcj.2016.10.

18.

The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.

Díaz-Beyá M, Brunet S, Nomdedéu J, Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I, Ribera JM, Duarte R, de Llano MP, Bargay J, Sampol A, Nomdedeu M, Risueño RM, Hoyos M, Sierra J, Monzo M, Navarro A, Esteve J; Cooperative AML group CETLAM.

Oncotarget. 2015 Oct 13;6(31):31613-27. doi: 10.18632/oncotarget.5148.

19.

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.

Díaz-Beyá M, Brunet S, Nomdedéu J, Cordeiro A, Tormo M, Escoda L, Ribera JM, Arnan M, Heras I, Gallardo D, Bargay J, Queipo de Llano MP, Salamero O, Martí JM, Sampol A, Pedro C, Hoyos M, Pratcorona M, Castellano JJ, Nomdedeu M, Risueño RM, Sierra J, Monzó M, Navarro A, Esteve J.

Blood Cancer J. 2015 Oct 2;5:e352. doi: 10.1038/bcj.2015.76.

20.

The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer.

Navarro A, Tejero R, Viñolas N, Cordeiro A, Marrades RM, Fuster D, Caritg O, Moises J, Muñoz C, Molins L, Ramirez J, Monzo M.

Oncotarget. 2015 Oct 13;6(31):31544-56. doi: 10.18632/oncotarget.3003.

21.

A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.

Navarro A, Díaz T, Tovar N, Pedrosa F, Tejero R, Cibeira MT, Magnano L, Rosiñol L, Monzó M, Bladé J, Fernández de Larrea C.

Oncotarget. 2015 Jan 30;6(3):1874-83.

22.

Epigenetic regulation of microRNA expression in Hodgkin lymphoma.

Navarro A, Díaz T, Cordeiro A, Beyá MD, Ferrer G, Fuster D, Martinez A, Monzó M.

Leuk Lymphoma. 2015;56(9):2683-9. doi: 10.3109/10428194.2014.995650. Epub 2015 Jun 18.

PMID:
25586608
23.

Differential MIR-21 expression in plasma from mesenteric versus peripheral veins: an observational study of disease-free survival in surgically resected colon cancer patients.

Monzo M, Martínez-Rodenas F, Moreno I, Navarro A, Santasusagna S, Macias I, Muñoz C, Tejero R, Hernández R.

Medicine (Baltimore). 2015 Jan;94(1):e145. doi: 10.1097/MD.0000000000000145.

24.

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.

Tejero R, Navarro A, Campayo M, Viñolas N, Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L, Ramirez J, Monzó M.

PLoS One. 2014 Jul 8;9(7):e101899. doi: 10.1371/journal.pone.0101899. eCollection 2014.

25.

miR-200 family in CRC primary tumors and metastases.

Diaz T, Moreno I, Monzo M.

J Surg Oncol. 2014 Sep;110(4):486. doi: 10.1002/jso.23683. Epub 2014 Jun 7. No abstract available.

PMID:
24910188
26.

High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome.

Calvo X, Nomdedeu M, Navarro A, Tejero R, Costa D, Muñoz C, Pereira A, Peña O, Risueño RM, Monzó M, Esteve J, Nomdedeu B.

Leuk Res. 2014 Aug;38(8):874-81. doi: 10.1016/j.leukres.2014.04.015. Epub 2014 May 12.

PMID:
24880536
27.

Role of miR-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines.

Diaz T, Tejero R, Moreno I, Ferrer G, Cordeiro A, Artells R, Navarro A, Hernandez R, Tapia G, Monzo M.

J Surg Oncol. 2014 Jun;109(7):676-83. doi: 10.1002/jso.23572. Epub 2014 Feb 10.

PMID:
24510588
28.

MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia.

Díaz-Beyá M, Brunet S, Nomdedéu J, Tejero R, Díaz T, Pratcorona M, Tormo M, Ribera JM, Escoda L, Duarte R, Gallardo D, Heras I, Queipo de Llano MP, Bargay J, Monzo M, Sierra J, Navarro A, Esteve J; Cooperative AML group CETLAM (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias).

Leukemia. 2014 Apr;28(4):804-12. doi: 10.1038/leu.2013.281. Epub 2013 Sep 27.

PMID:
24072101
29.

Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2.

Marín-Béjar O, Marchese FP, Athie A, Sánchez Y, González J, Segura V, Huang L, Moreno I, Navarro A, Monzó M, García-Foncillas J, Rinn JL, Guo S, Huarte M.

Genome Biol. 2013;14(9):R104.

30.

MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients.

Navarro A, Muñoz C, Gaya A, Díaz-Beyá M, Gel B, Tejero R, Díaz T, Martinez A, Monzó M.

PLoS One. 2013 May 21;8(5):e64716. doi: 10.1371/journal.pone.0064716. Print 2013.

31.
32.

Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib.

Fernández de Larrea C, Martín-Antonio B, Cibeira MT, Navarro A, Tovar N, Díaz T, Rosiñol L, Monzó M, Urbano-Ispizua A, Bladé J.

Leuk Res. 2013 Jun;37(6):641-6. doi: 10.1016/j.leukres.2013.01.013. Epub 2013 Feb 8.

PMID:
23395385
33.

MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.

Ferrer G, Navarro A, Hodgson K, Aymerich M, Pereira A, Baumann T, Monzo M, Moreno C, Montserrat E.

Leuk Lymphoma. 2013 Sep;54(9):2016-22. doi: 10.3109/10428194.2012.763123. Epub 2013 Jan 29.

PMID:
23286334
34.

Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.

Díaz-Beyá M, Navarro A, Ferrer G, Díaz T, Gel B, Camós M, Pratcorona M, Torrebadell M, Rozman M, Colomer D, Monzo M, Esteve J.

Leukemia. 2013 Mar;27(3):595-603. doi: 10.1038/leu.2012.278. Epub 2012 Oct 1.

PMID:
23022987
35.

Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer.

Campayo M, Navarro A, Viñolas N, Diaz T, Tejero R, Gimferrer JM, Molins L, Cabanas ML, Ramirez J, Monzo M, Marrades R.

Eur Respir J. 2013 May;41(5):1172-8. doi: 10.1183/09031936.00048712. Epub 2012 Jul 26.

36.

Expression of myosin heavy chain isoforms in the human supraspinatus muscle: variations related to age and sex.

Potau JM, Artells R, Muñoz C, Díaz T, Bello-Hellegouarch G, Arias-Martorell J, Pérez-Pérez A, Monzó M.

Cells Tissues Organs. 2012;196(5):456-62. doi: 10.1159/000336680. Epub 2012 Jun 12.

PMID:
22699393
37.

Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.

de Larrea CF, Navarro A, Tejero R, Tovar N, Díaz T, Cibeira MT, Rosiñol L, Ferrer G, Rovira M, Rozman M, Monzó M, Bladé J.

Clin Cancer Res. 2012 Jul 1;18(13):3697-704. doi: 10.1158/1078-0432.CCR-12-0191. Epub 2012 Apr 26.

38.

Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial.

Bosch X, Esteve J, Sitges M, de Caralt TM, Domènech A, Ortiz JT, Monzó M, Morales-Ruiz M, Perea RJ, Rovira M.

J Card Fail. 2011 Aug;17(8):643-8. doi: 10.1016/j.cardfail.2011.03.008. Epub 2011 May 6.

PMID:
21807325
39.

A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.

Campayo M, Navarro A, Viñolas N, Tejero R, Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P, Ramirez J, Monzo M.

PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.

40.

Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis.

Diaz T, Navarro A, Ferrer G, Gel B, Gaya A, Artells R, Bellosillo B, Garcia-Garcia M, Serrano S, Martínez A, Monzo M.

PLoS One. 2011 Apr 20;6(4):e18856. doi: 10.1371/journal.pone.0018856.

41.

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide.

Cibeira MT, de Larrea CF, Navarro A, Díaz T, Fuster D, Tovar N, Rosiñol L, Monzó M, Bladé J.

Leuk Res. 2011 Sep;35(9):1178-83. doi: 10.1016/j.leukres.2011.02.009. Epub 2011 Mar 23.

PMID:
21435719
42.

Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.

Navarro A, Diaz T, Gallardo E, Viñolas N, Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

J Surg Oncol. 2011 Apr;103(5):411-5. doi: 10.1002/jso.21847. Epub 2010 Dec 29.

PMID:
21400525
43.

Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.

Campayo M, Viñolas N, Navarro A, Carcereny E, Casas F, Gel B, Diaz T, Gimferrer JM, Marrades RM, Ramirez J, Monzo M.

J Surg Res. 2011 May 1;167(1):e5-12. doi: 10.1016/j.jss.2011.01.007. Epub 2011 Feb 2.

PMID:
21324488
44.

Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestine.

Artells R, Navarro A, Diaz T, Monzó M.

Anat Rec (Hoboken). 2011 Mar;294(3):462-71. doi: 10.1002/ar.21333. Epub 2011 Jan 31.

45.

MicroRNAs in human embryonic and cancer stem cells.

Navarro A, Monzo M.

Yonsei Med J. 2010 Sep;51(5):622-32. doi: 10.3349/ymj.2010.51.5.622.

46.

Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.

Artells R, Moreno I, Díaz T, Martínez F, Gel B, Navarro A, Ibeas R, Moreno J, Monzó M.

Eur J Cancer. 2010 Feb;46(3):642-9. doi: 10.1016/j.ejca.2009.11.003. Epub 2009 Dec 11.

PMID:
20005089
47.

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T, Valera S, Rozman M, Belkaid M, Montserrat E, Monzo M.

Leuk Lymphoma. 2009 Nov;50(11):1854-9. doi: 10.3109/10428190903147645.

PMID:
19883312
48.

Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients.

Grau JJ, Caballero M, Verger E, Monzó M, Blanch JL.

Acta Otolaryngol. 2009 Nov;129(11):1294-9. doi: 10.3109/00016480802590451.

PMID:
19863327
49.

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

Carcinogenesis. 2009 Nov;30(11):1903-9. doi: 10.1093/carcin/bgp219. Epub 2009 Sep 7.

PMID:
19736307
50.

Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.

Navarro A, Diaz T, Martinez A, Gaya A, Pons A, Gel B, Codony C, Ferrer G, Martinez C, Montserrat E, Monzo M.

Blood. 2009 Oct 1;114(14):2945-51. doi: 10.1182/blood-2009-02-204842. Epub 2009 Aug 7.

PMID:
19666866

Supplemental Content

Support Center